Insulet Corp said on Wednesday it received a warning letter from the U.S. Food and Drug Administration over some of the company’s insulin pumps.
The company said the letter, which it received on Monday, followed an inspection by the FDA of its facility in Billerica, Massachusetts in March.
At that time, the FDA had issued a Form 483 and the company filed its response letter in April.
Help employers find you! Check out all the jobs and post your resume.
